Interim Analysis Results of a Phase 2 Trial of Low-Dose Radiation Therapy for Palliation of Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Furlan, C. [1 ]
Bulian, P. [1 ]
Spina, M. [1 ]
Michieli, M. [1 ]
Ermacora, A. [2 ]
Tirelli, U. [1 ]
Trovo, M. [1 ]
机构：
[1] CRO Aviano Natl Canc Inst, Aviano, Italy
[2] Osped Santa Maria degli Angeli, Pordenone, Italy
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
171
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [21] Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)
    Sehn, Laurie H.
    Hardy, Edward L. G.
    Gill, Karamjit K.
    Al-Tourah, Abdulwahab J.
    Shustik, Jesse
    Macpherson, Nicol A.
    Yee, Adrian
    Lam, Wendy
    Savage, Kerry J.
    Klasa, Richard
    Villa, Diego
    Gerrie, Alina S.
    Shenkier, Tamara
    Slack, Graham W.
    Gascoyne, Randy D.
    Benard, Francois
    Wilson, Don
    Tonseth, Peter
    Connors, Joseph M.
    BLOOD, 2014, 124 (21)
  • [22] Highly Radiosensitive Diffuse Large B-cell Lymphoma of the Skull Treated With Low-Dose CyberKnife Radiotherapy: A Case Report
    Mizumatsu, Shinichiro
    Nomura, Ryutaro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [23] Interim PET-CT in the management of diffuse large B-cell lymphoma
    Moskowitz, Craig H.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2012, : 397 - 401
  • [24] Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
    Fjorden, Karin
    Ekberg, Sara
    Kuric, Nevzeta
    Smedby, Karin E.
    Lagerlof, Ingemar
    Larsen, Thomas S.
    Jorgensen, Judit M.
    de Nully Brown, Peter
    Jerkeman, Mats
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 437 - 440
  • [25] SD-101, a novel intratumoral class C CpG-ODN, given with low-dose radiation in patients with untreated low-grade B-cell lymphoma: interim results of a phase I trial
    Levy, Ronald
    Bartlett, Nancy
    Friedberg, Jonathan
    Reagan, Patrick
    Gordon, Leo
    Bergman, Craig
    Coffman, Robert
    Janssen, Robert
    Candia, Albert
    Khodadoust, Michael
    Frank, Matthew
    Long, Steven
    Czerwinski, Debra
    Chu, Michael
    Kohrt, Holbrook
    CANCER RESEARCH, 2016, 76
  • [26] Results of CHOP chemotherapy for diffuse large B-cell lymphoma
    Hallack Neto, A. E.
    Pereira, J.
    Beitler, B.
    Chamone, D. A. F.
    Llacer, P. D.
    Dulley, F. L.
    Macedo, M. C. M. A.
    Chaoubah, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (10) : 1315 - 1322
  • [27] Diffuse large B-cell lymphoma: An institutional analysis
    Gogia, Ajay
    Das, Chandan K.
    Kumar, Lalit
    Sharma, Atul
    Tiwari, Akash
    Sharma, M. C.
    Mallick, Soumya
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (03) : 200 - 202
  • [28] The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma
    Ellmann, Annare
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (01) : 40 - 42
  • [29] Response-adapted therapy for limited stage diffuse large B-cell lymphoma based on interim PET-CT: preliminary results of a phase 2 study
    Lv, Fangfang
    Xia, Zuguang
    Xue, Kai
    Zhang, Qunling
    Ji, Dongmei
    Cao, Junning
    Hong, Xiaonan
    Guo, Ye
    LANCET ONCOLOGY, 2017, 18 : S10 - S10
  • [30] A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Collins, Graham P.
    Toby, Eyre A.
    Hatton, Chris S.
    Radford, John
    Linton, Kim M.
    BLOOD, 2014, 124 (21)
12345